KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Change in Intangibles (2023 - 2024)

Historic Change in Intangibles for Rigel Pharmaceuticals (RIGL) over the last 2 years, with Q2 2024 value amounting to $222000.0.

  • Rigel Pharmaceuticals' Change in Intangibles changed N/A to $222000.0 in Q2 2024 from the same period last year, while for Dec 2024 it was $360000.0, marking a year-over-year decrease of 9760.0%. This contributed to the annual value of $360000.0 for FY2024, which is 9760.0% down from last year.
  • Rigel Pharmaceuticals' Change in Intangibles amounted to $222000.0 in Q2 2024.
  • In the past 5 years, Rigel Pharmaceuticals' Change in Intangibles ranged from a high of $15.0 million in Q1 2023 and a low of $138000.0 during Q1 2024